---
$id: https://graph.org.ai/products/commodity/51392303
$type: Product
source: UNSPSC
code: "51392303"
title: "Medorinone"
class: "51392300"
classTitle: "Sympathomimetic or adrenergic isoquinolines and isoxazoles and naphthyridines and phenoxypropanolamines"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Medorinone

**UNSPSC Code**: 51392303
**Class**: [Sympathomimetic or adrenergic isoquinolines and isoxazoles and naphthyridines and phenoxypropanolamines](Sympathomimetic or adrenergic isoquinolines and isoxazoles and naphthyridines and phenoxypropanolamines.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C9H8N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80X61Y4X0B, chemically known as 1,6-naphthyridin-2(1h)-one, 5-methyl- but generally known as medorinone, which bears US NIH Compound Identifier 5362132. European Medicines Agency schedules Medorinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08694MIG. The term MEDORINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). MEDORINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule medorinone under HS 29337900 and SITC 51561. As of Q4 2014, MEDORINONE remains the US FDA Preferred Term for this commodity. Medorinone bears US NLM identifiers UMLS ID C0641935 and NCI Concept Code C74352. SMILES: O=C1[NH]C2C(C(NCC2)C)CC1.

